Home › Myeloproliferative Neoplasms › Vermont
Myeloproliferative Neoplasms clinical trials in Vermont
3 studies for Myeloproliferative Neoplasms are looking for participants at sites in Vermont.
Cities in Vermont
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05564390Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
RecruitingPhase 2
Ages 18 to 59 · All sexes · Updated Sep 22, 2026 · NCT05554406Project: Every Child for Younger Patients With Cancer
- University of Vermont and State Agricultural College, Burlington
RecruitingObservational study
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.